Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
American Journal of Physiology. Cell Physiology|March 27, 2015
PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growthOmran Abu Aboud, Dallas Donohoe, Scott Bultman, et al.
Journal of Sports Sciences|October 6, 2012
Urine dipstick analysis for identification of runners susceptible to acute kidney injury following an ultramarathonMartin D Hoffman, Kristin J Stuempfle, Kevin Fogard, et al.
Molecular & Cellular Proteomics : MCP|November 15, 2008
Urine metabolomics analysis for kidney cancer detection and biomarker discoveryKyoungmi Kim, Pavel Aronov, Stanislav O Zakharkin, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2016
The Nephrologist's Tumor: Basic Biology and Management of Renal Cell CarcinomaSusie L Hu, Anthony Chang, Mark A Perazella, et al.
Expert Opinion on Therapeutic Targets|December 7, 2017
Rho GTPase effectors and NAD metabolism in cancer immune suppressionMahmoud Chaker, Audrey Minden, Suzie Chen, et al.
Molecular Cancer Therapeutics|August 13, 2009
Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivoJun-Yan Liu, See-Hyoung Park, Christophe Morisseau, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2002
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferationBenjamin B Davis, David A Thompson, Laura L Howard, et al.
Beilstein Journal of Organic Chemistry|February 13, 2013
From bead to flask: Synthesis of a complex β-amido-amide for probe-development studiesKevin S Martin, Cristian Soldi, Kellan N Candee, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 14, 2005
Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibitionBenjamin B Davis, Christophe Morisseau, John W Newman, et al.
Molecular Cancer|November 25, 2006
Pathway analysis of kidney cancer using proteomics and metabolic profilingBertrand Perroud, Jinoo Lee, Nelly Valkova, et al.
Pageof 10